ELIZABETH PULLMAN: Open Payments
NPI 1932808714 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 7 payments from 5 companies in 2025. Trend: 2023 $199 · 2024 $147 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $99 |
| SHIELD THERAPEUTICS INC | 1 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| Biogen, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: GEMTESA, MYFEMBREE, ACCRUFER, ZURZUVAE, Veozah.
Industry payments across TX — which companies pay providers there.
